We are in a hurry to announce important news!
Following the principles of social orientation, the management of ACADEMPHARM decided to reduce the cost of all dosages of RIVAXAN (rivaroxaban, anticoagulant), so that this drug would become available to a wider range of consumers.
Information about the drug (instructions) is available at the link: https://academpharm.by/en/product/rivaxan
To learn more about the problem of thromboembolism (blood clots), follow the link: https://pro-tromboz.by/